Literature DB >> 31970841

Decreased markers of bone turnover in children and adolescents with type 1 diabetes.

Jens Otto Broby Madsen1, Camilla Winther Herskin1, Bo Zerahn2, Niklas Rye Jørgensen3,4, Birthe Susanne Olsen1, Flemming Pociot1,5,6, Jesper Johannesen1,5.   

Abstract

BACKGROUND AND AIM: Adults with type 1 diabetes (T1D) have increased risk of bone fractures and decreased bone mineral density (BMD). Alterations in bone turnover have been suggested as the link between T1D and the impaired bone health. Furthermore, bone turnover has been suggested to have beneficial effects on glucose metabolism. This study aimed at describing bone turnover markers (BTM), and the relationship with glycemic control, in children and adolescents with T1D.
METHODS: A total of 173 (47% girls) children and adolescents aged 7.7 to 17.5 years with T1D for more than 1 year were included. Participants were evaluated by BMD together with measurements of selected BTM; two formation markers: osteocalcin (OCN) and procollagen type-1 amino-terminal propeptide (P1NP) and one resorption marker, C-terminal cross-linked telopeptide of type-1 collagen (CTX). BTM were converted into Z-scores utilizing new national references.
RESULTS: Mean OCN Z-score (-0.68 ± 1.31), P1NP Z-score (-0.33 ± 1.03) and CTX Z-score (-0.43 ± 1.10) were all significantly lower than the reference population (P < .001). No associations were seen between BTM and T1D duration. BMD Z-score was comparable to the reference population and associated with none of individual BTMs. CTX Z-score was negatively associated with HbA1c (P = .007) independent of both exogenous and residual endogenous insulin.
CONCLUSIONS: Markers of bone formation and resorption were decreased in children and adolescents with T1D. CTX Z-score associated negatively with HbA1c adjusted for insulin treatment and endogenous insulin production indicating a potential association between CTX and insulin sensitivity. The long-term consequences of decreased BTM on BMD need further attention.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-terminal telopeptide of type I collagen; bone density; bone remodeling; diabetes mellitus, type 1; osteocalcin

Mesh:

Substances:

Year:  2020        PMID: 31970841     DOI: 10.1111/pedi.12987

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  7 in total

Review 1.  Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes.

Authors:  Callie Travis; Priya S Srivastava; Thomas J Hawke; Evangelia Kalaitzoglou
Journal:  J Diabetes Res       Date:  2022-05-12       Impact factor: 4.061

2.  Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.

Authors:  Nick Hildebrandt; Juliane Colditz; Lorenz C Hofbauer; Martina Rauner; Caio Dutra; Paula Goes; Juliane Salbach-Hirsch; Sylvia Thiele
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

3.  Bone Density, Geometry, and Mass by Peripheral Quantitative Computed Tomography and Bone Turnover Markers in Children with Diabetes Mellitus Type 1.

Authors:  Maciej Jaworski; Elżbieta Wierzbicka; Edyta Czekuć-Kryśkiewicz; Paweł Płudowski; Maria Kobylińska; Mieczysaw Szalecki
Journal:  J Diabetes Res       Date:  2022-04-18       Impact factor: 4.061

Review 4.  Fracture risk assessment in diabetes mellitus.

Authors:  Weiwei Chen; Min Mao; Jin Fang; Yikai Xie; Yongjun Rui
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-02       Impact factor: 6.055

5.  Childhood type 1 diabetes is associated with abnormal bone development.

Authors:  Komal Ashokbhai Vora; Craig F Munns; Kim C Donaghue; Maria E Craig; Julie Briody; Paul Benitez-Aguirre
Journal:  Pediatr Diabetes       Date:  2022-06-06       Impact factor: 3.409

Review 6.  Mechanisms of altered bone remodeling in children with type 1 diabetes.

Authors:  Giacomina Brunetti; Gabriele D'Amato; Stefania De Santis; Maria Grano; Maria Felicia Faienza
Journal:  World J Diabetes       Date:  2021-07-15

Review 7.  Future studies using histomorphometry in type 1 diabetes mellitus.

Authors:  Laura A Graeff-Armas; Emily Silverman; Robert R Recker
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-08-01       Impact factor: 3.626

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.